Novartis AG - Common Stock - Foreign

Historical Holders from Q1 2014 to Q3 2025

Type / Class
Equity / Common Stock - Foreign
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
437,106
Holdings value
$54,976,712
% of all portfolios
0%
Number of holders
2
Number of buys
1
Number of sells
-1
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Novartis AG - Common Stock - Foreign

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 437,106 $54,976,712 -$477,211 $125.8 2
2025 Q2 440,894 $53,424,708 +$49,093,182 $121.01 2
2025 Q1 35,851 $3,964,582 -$2,197,479 $110.59 2
2024 Q4 58,301 $5,706,211 +$3,137,604 $97.88 3
2024 Q3 26,244 $3,022,345 +$30,304 $114.98 2
2024 Q2 25,980 $2,780,434 -$460,195 $107.03 2
2024 Q1 30,280 $2,937,222 +$1,063,719 $96.94 2
2023 Q4 19,314 $1,947,578 -$77,141 $100.84 1
2023 Q3 20,079 $2,060,358 +$1,094,363 $102.61 1
2023 Q2 9,414 $947,030 $100.6 1
2023 Q1 9,414 $863,135 -$660,141 $91.69 1
2022 Q4 16,614 $1,501,042 +$200,031 $90.35 1
2022 Q3 14,400 $1,105,036 $76.74 1
2022 Q2 14,400 $1,216,107 -$28,223,893 $84.45 1
2022 Q1 323,370 $29,440,000 +$1,477,781 $91.04 1
2021 Q4 307,138 $27,993,000 +$3,454,261 $91.14 1
2021 Q3 269,238 $22,468,000 +$4,076,882 $83.45 1
2021 Q2 220,384 $20,081,000 -$11,096,743 $91.12 1
2021 Q1 342,168 $26,909,000 -$1,832,045 $78.64 1
2020 Q4 361,405 $31,273,140 +$15,622,035 $90.35 2
2020 Q3 179,877 $15,266,319 +$1,832,606 $85.79 2
2020 Q2 158,244 $13,771,662 +$2,120,677 $87.01 2
2020 Q1 133,878 $11,117,033 +$3,567,972 $82.83 2
2019 Q4 90,818 $8,632,000 +$1,093,804 $95.05 1
2019 Q3 79,310 $6,879,000 +$427,260 $86.74 1
2019 Q2 74,384 $6,796,000 +$541,787 $91.36 1
2019 Q1 68,454 $6,588,000 +$1,962,907 $96.24 1
2018 Q4 48,058 $4,094,000 +$110,234 $85.19 1
2018 Q3 46,764 $4,020,000 +$208,548 $85.96 1
2018 Q2 44,338 $3,369,000 +$824,204 $75.98 1
2018 Q1 33,491 $2,712,000 +$558,012 $80.98 1
2017 Q4 26,600 $2,249,000 +$25,365 $84.55 1
2017 Q3 26,300 $2,253,000 +$2,253,000 $85.67 1
2016 Q4 0 $0 -$18,915,000 0
2016 Q3 239,983 $18,915,000 -$1,489,805 $78.82 2
2016 Q2 258,035 $21,226,000 -$940,506 $82.27 3
2016 Q1 270,627 $19,692,000 +$1,020,095 $72.78 4
2015 Q4 256,610 $22,304,000 -$274,719,311 $86.72 3
2015 Q3 3,259,221 $298,210,140 -$298,636,482 $91.5 5
2015 Q2 3,290,459 $324,454,068 +$69,960,210 $98.6 6
2015 Q1 2,580,948 $255,492,881 -$888,989 $98.99 6
2014 Q4 2,589,929 $240,742,350 +$1,868,333 $92.94 5
2014 Q3 2,498,914 $235,768,871 +$24,600,496 $94.35 3
2014 Q2 2,309,770 $209,150,376 +$193,779,606 $90.55 6
2014 Q1 169,750 $14,412,260 +$192,107 $84.9 2